21 authors at 9 institutions in 5 countries.
Sarah V WardMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Isidora AutuoriMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Li LuoDepartment of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.ORCID 0000-0003-0728-8628 Emily LaPillaMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sarah YooMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ajay SharmaMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Klaus J BusamMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
David W OlillaLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
Terence DwyerClinical Sciences Theme, Heart Group, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.ORCID 0000-0002-2091-7663 Hoda Anton-CulverDepartment of Medicine, University of California, Irvine, CA 92617, USA.
Roberto ZanettiPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Lidia SacchettoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Anne E CustThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.ORCID 0000-0002-5331-6370 Richard P GallagherBC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-5567-9618 Stefano RossoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.ORCID 0000-0001-6816-2661 Colin B BeggMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Marianne BerwickDepartment of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.
Nancy E ThomasLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
GEM Study Group
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MVirology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5MSex Differences in Methylome Alterations and Mutational Burden in Early Stage MelanomaP01CA206980 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BERWICK, MARIANNE, THOMAS, NANCY E. · 2017 to 2022
$10.1MMelanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4MA MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMAU01CA083180 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 1999 to 2003
$5.2MIdentification of Lethal Melanomas at the Time of DiagnosisR01CA233524 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANTON-CULVER, HODA A, BEGG, COLIN B · 2020 to 2024
$4.5MSolar Exposure and Melanoma SurvivalR01CA112524 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 2005 to 2009
$2.5MEpidemiologic Parameters of Rare Cancer Risk FactorsR01CA098438 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BEGG, COLIN B · 2003 to 2005
$839kValidation of the use of whole-genome amplified DNA in a population-based studyR03CA173806 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2013 to 2014
$170kMutational Analysis of Clonality in Multiple Primary MelanomaR03CA125829 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2006 to 2007
$128k